Immune-blotting tests of colorectal cancer patients sera with two colorectal cancer cell lines 4
IgG level in serum samples
Previous to performing additional examinations of the differences seen in the immune reactivity pattern between various patients' subsets and extracted cells lysate, we first required to eliminate the possibility that the differences seen by western blotting were just a reflection of important gaps in the quantity of total IgG existing in the sera tested. Consequently, we measured the level of total IgG in all samples. According to the results, we cannot find significant differences in serum IgG titer between the individual samples [Supplement Table 1 ].
Sera from colorectal cancer patients show different immune reactivity to SW48 cell lysate compared with normal serum Cancer patients' sera may contain antibodies that are specific for TAAs and can be used for disease detection. As a result, antibodies present in the serum of CRC patients might be considered as diagnostic and prognostic biomarkers in CRC. Patients were classified according to clinical and pathological data, and their sera were collected. Lysates of different cell lines were incubated with patients' sera for western blot analysis. For instance, 
